Genes and Development

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


GENES & DEVELOPMENT 20:1539-1544, 2006
©2006 by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/ $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlissel, M. S.
Right arrow Articles by Curry, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlissel, M. S.
Right arrow Articles by Curry, J. D.
Related Content
Right arrow DNA Replication, Recombination, and Repair
Right arrow Immunology
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

PERSPECTIVE

Leukemia and lymphoma: a cost of doing business for adaptive immunity

Mark S. Schlissel1, Chris R. Kaffer and John D. Curry

Division of Immunology, Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94720, USA

The first 100 words of the full text of this article appear below.

According to the old adage, "you don’t get something for nothing." This is certainly the case for the novel genetic mechanisms involved in adaptive immunity—V(D)J recombination, class-switch recombination (CSR), and somatic hypermutation (SHM). These mechanisms allow animals to respond with great specificity to a seemingly limitless array of rapidly evolving microbes and their products while investing a relatively small amount of genetic capacity. The cost, however, is genomic instability and its potential contribution to malignancy. A majority of B- and T-cell leukemias and lymphomas are associated with chromosomal abnormalities that bear the hallmarks of aberrant V(D)J or class-switch recombination. In . . . [Full Text of this Article]


    Novel mechanisms regulating antigen receptor genes in lymphocytes
 

    Chromosomal translocations and lymphoid malignancy
 

    The V(D)J recombinase and genomic instability
 

    The V(D)J recombinase is a transposase
 

    Detection and quantification of RSS fragment transposition
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Genomic instability due to V(D)J recombination-associated transposition
Yeturu V.R. Reddy, Eric J. Perkins, and Dale A. Ramsden
Genes & Dev. 2006 20: 1575-1582. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Exp. Med.Home page
J. D. Curry, D. Schulz, C. J. Guidos, J. S. Danska, L. Nutter, A. Nussenzweig, and M. S. Schlissel
Chromosomal reinsertion of broken RSS ends during T cell development
J. Exp. Med., October 1, 2007; 204(10): 2293 - 2303.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Genome Res. Learn. Mem.
Protein Science RNA Genes Dev.
Copyright © 2006 by Cold Spring Harbor Laboratory Press.